Blue Owl–Sila Realty Deal Clears Shareholder Vote: What the $2.4B Healthcare REIT Buyout Means for Traders

Event Analysis

Shareholders of Sila Realty Trust, Inc. (NYSE: SILA) have approved the all-cash acquisition by affiliates of Blue Owl Capital Inc. — a key milestone clearing one of the final hurdles in a $2.4 billion deal announced on April 20, 2026. According to Sila's investor relations press release and SEC filings, Blue Owl's affiliates will pay $30.38 per share in cash, representing a 19% premium to SILA's pre-announcement closing price of $25.53 and a 25.6% premium to the 30-day VWAP. The deal is expected to close in Q2–Q3 2026, subject to remaining customary conditions.

What distinguishes this transaction is its fit within a clear structural trend: private alternative asset managers acquiring listed REITs at premiums when public-market valuations lag private-market pricing. Blue Owl is acquiring 137 healthcare properties plus 3 land parcels across 65 U.S. markets — all under long-term triple-net leases. This is precisely the kind of inflation-linked, defensive cash-flow asset that institutional capital has been aggressively chasing. As reported by Reuters, SILA jumped roughly 19% on the announcement — the market immediately validated the deal's credibility.

This acquisition fits squarely into the broader M&A acquisition wave reshaping listed real estate. Private capital — particularly alt-asset managers with permanent capital structures like Blue Owl — continues to see listed REITs as undervalued relative to private-market appraisals. Each completed deal compresses the listed discount and raises the takeover premium expectations for surviving public healthcare REITs. Shareholder approval materially de-risks the remaining path to close, with antitrust concerns considered minimal given healthcare real estate's fragmented nature.

What This Means for Traders

SILA is now a pure merger-arb instrument. With a fixed cash takeout at $30.38, the stock trades at a small discount reflecting residual time value and closing risk. Shareholder approval narrows the deal-break probability significantly — the spread should tighten further into closing. The primary remaining risk is financing or regulatory delay, not deal rejection. Traders playing acquisition arbitrage should size positions against the annualized yield implied by the remaining spread, weighted by closure probability.

OWL offers the strategic angle. According to Reuters, OWL shares were little changed on the announcement day (up ~0.5%), reflecting that the market views this as incrementally accretive rather than transformational. However, the acquisition expands Blue Owl's fee-earning AUM in net-lease healthcare — a growing sleeve of its real estate platform. OWL's stock CFDs trade 24/7 on CoinUnited.io, meaning traders can respond immediately to any post-hours developments (financing announcements, closing confirmations) without waiting for NYSE open.

Sector read-through is bullish for healthcare REIT peers. The deal validates private-market valuations for net-lease healthcare assets and reduces the listed investable universe by one name. REIT index funds will need to reallocate on SILA's eventual delisting, creating incremental passive inflows into comparable listed peers. This is a textbook example of cross-sector acquisition repricing — where a completed deal lifts valuation floors across an entire sub-sector.

Start Trading on CoinUnited.io

Create Your Free Account → — Trade crypto, stocks, forex, indices, and commodities with up to 2000x leverage and zero fees.